BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 1471216)

  • 1. Non-genotoxic factors in the carcinogenetic process: problems of detection and hazard evaluation.
    Parodi S; Malacarne D; Taningher M
    Toxicol Lett; 1992 Dec; 64-65 Spec No():621-30. PubMed ID: 1471216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic events during the process of cell transformation induced by carcinogens (review).
    Nguyen-Ba G; Vasseur P
    Oncol Rep; 1999; 6(4):925-32. PubMed ID: 10373683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach.
    Hernández LG; van Steeg H; Luijten M; van Benthem J
    Mutat Res; 2009; 682(2-3):94-109. PubMed ID: 19631282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction and distinction of genotoxic and non-genotoxic events in carcinogenesis.
    Yamasaki H; Mesnil M; Nakazawa H
    Toxicol Lett; 1992 Dec; 64-65 Spec No():597-604. PubMed ID: 1471213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of non-genotoxic carcinogenesis.
    Shaw IC; Jones HB
    Trends Pharmacol Sci; 1994 Mar; 15(3):89-93. PubMed ID: 8184492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 55 different human carcinogen exposures.
    Ashby J; Paton D
    Mutat Res; 1993 Mar; 286(1):3-74. PubMed ID: 7678908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The relation between carcinogenesis and mutagenesis: a re-evaluation].
    Bartsch H; Malaveille C
    Bull Acad Natl Med; 1989 Nov; 173(8):1005-12; discussion 1013-5. PubMed ID: 2633853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
    Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of hepatocarcinogen-induced gene expression profiles in conventional primary rat hepatocytes with in vivo rat liver.
    Doktorova TY; Ellinger-Ziegelbauer H; Vinken M; Vanhaecke T; van Delft J; Kleinjans J; Ahr HJ; Rogiers V
    Arch Toxicol; 2012 Sep; 86(9):1399-411. PubMed ID: 22484513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qualitative and quantitative approaches in the dose-response assessment of genotoxic carcinogens.
    Fukushima S; Gi M; Kakehashi A; Wanibuchi H; Matsumoto M
    Mutagenesis; 2016 May; 31(3):341-6. PubMed ID: 26152227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-genotoxic carcinogenesis: implications for testing and extrapolation to man.
    Roe FJ
    Mutagenesis; 1989 Nov; 4(6):407-11. PubMed ID: 2695753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal mouse model: review of methods and results.
    McClain RM; Keller D; Casciano D; Fu P; MacDonald J; Popp J; Sagartz J
    Toxicol Pathol; 2001; 29 Suppl():128-37. PubMed ID: 11695548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An integrative test strategy for cancer hazard identification.
    Luijten M; Olthof ED; Hakkert BC; Rorije E; van der Laan JW; Woutersen RA; van Benthem J
    Crit Rev Toxicol; 2016 Aug; 46(7):615-39. PubMed ID: 27142259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pollution, carcinogenesis and cancer prevention.
    Ramel C
    Acta Oncol; 1991; 30(6 Spec No):27-33. PubMed ID: 1910870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic alterations induced by genotoxic occupational and environmental human chemical carcinogens: A systematic literature review.
    Chappell G; Pogribny IP; Guyton KZ; Rusyn I
    Mutat Res Rev Mutat Res; 2016; 768():27-45. PubMed ID: 27234561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of genotoxic and non-genotoxic carcinogens in Xpc(-/-)p53(+/-) mice.
    Melis JP; Speksnijder EN; Kuiper RV; Salvatori DC; Schaap MM; Maas S; Robinson J; Verhoef A; van Benthem J; Luijten M; van Steeg H
    Toxicol Appl Pharmacol; 2013 Jan; 266(2):289-97. PubMed ID: 23153559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive and carcinogen-derived DNA binding as a basis for the assessment of potency of chemical carcinogens.
    Lutz WK
    Adv Exp Med Biol; 1981; 136 Pt B():1349-65. PubMed ID: 7344514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is current risk assessment of non-genotoxic carcinogens protective?
    Braakhuis HM; Slob W; Olthof ED; Wolterink G; Zwart EP; Gremmer ER; Rorije E; van Benthem J; Woutersen R; van der Laan JW; Luijten M
    Crit Rev Toxicol; 2018 Jul; 48(6):500-511. PubMed ID: 29745287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are genotoxic carcinogens more potent than nongenotoxic carcinogens?
    Parodi S; Malacarne D; Romano P; Taningher M
    Environ Health Perspect; 1991 Nov; 95():199-204. PubMed ID: 1821372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.